Epidemiology and Health-Related Quality of Life in Hypoparathyroidism in Norway
Open Access
- 1 August 2016
- journal article
- other
- Published by The Endocrine Society in The Journal of Clinical Endocrinology & Metabolism
- Vol. 101 (8) , 3045-3053
Abstract
Objective: The epidemiology of hypoparathyroidism (HP) is largely unknown. We aimed to determine prevalence, etiologies, health related quality of life (HRQOL) and treatment pattern of HP. Methods: Patients with HP and 22q11 deletion syndrome (DiGeorge syndrome) were identified in electronic hospital registries. All identified patients were invited to participate in a survey. Among patients who responded, HRQOL was determined by Short Form 36 and Hospital Anxiety and Depression scale. Autoantibodies were measured and candidate genes (CaSR, AIRE, GATA3, and 22q11-deletion) were sequenced for classification of etiology. Results: We identified 522 patients (511 alive) and estimated overall prevalence at 102 per million divided among postsurgical HP (64 per million), nonsurgical HP (30 per million), and pseudo-HP (8 per million). Nonsurgical HP comprised autosomal dominant hypocalcemia (21%), autoimmune polyendocrine syndrome type 1 (17%), DiGeorge/22q11 deletion syndrome (15%), idiopathic HP (44%), and others (4%). Among the 283 respondents (median age, 53 years [range, 9–89], 75% females), seven formerly classified as idiopathic were reclassified after genetic and immunological analyses, whereas 26 (37% of nonsurgical HP) remained idiopathic. Most were treated with vitamin D (94%) and calcium (70%), and 10 received PTH. HP patients scored significantly worse than the normative population on Short Form 36 and Hospital Anxiety and Depression scale; patients with postsurgical scored worse than those with nonsurgical HP and pseudo-HP, especially on physical health. Conclusions: We found higher prevalence of nonsurgical HP in Norway than reported elsewhere. Genetic testing and autoimmunity screening of idiopathic HP identified a specific cause in 21%. Further research is necessary to unravel the causes of idiopathic HP and to improve the reduced HRQOL reported by HP patients. A Norwegian national survey revealed higher prevalence of non-surgical and lower prevalence of post-surgical hypoparathyroidism than expected. Patients with hypoparathyroidism have reduced HRQoL.Keywords
This publication has 45 references indexed in Scilit:
- Effects of PTH(1–84) therapy on muscle function and quality of life in hypoparathyroidism: results from a randomized controlled trialOsteoporosis International, 2014
- The Syndrome of Hypoparathyroidism, Deafness, and Renal AnomaliesEndocrine Practice, 2013
- Hypoparathyroidism in the adult: Epidemiology, diagnosis, pathophysiology, target-organ involvement, treatment, and challenges for future researchJournal of Bone and Mineral Research, 2011
- Radioimmunoassay for autoantibodies against interferon omega; its use in the diagnosis of autoimmune polyendocrine syndrome type IClinical Immunology, 2008
- Dominant-NegativeGCMBMutations Cause an Autosomal Dominant Form of HypoparathyroidismThe Journal of Clinical Endocrinology & Metabolism, 2008
- Autoimmune Polyendocrine Syndrome Type 1 and NALP5, a Parathyroid AutoantigenNew England Journal of Medicine, 2008
- Mutation of TBCE causes hypoparathyroidism– retardation–dysmorphism and autosomal recessive Kenny–Caffey syndromeNature Genetics, 2002
- Subjective health status in Norwegian patients with Addison’s disease*Clinical Endocrinology, 2002
- Well-being, mood and calcium homeostasis in patients with hypoparathyroidism receiving standard treatment with calcium and vitamin DEuropean Journal of Endocrinology, 2002
- Short Form 36 (SF-36) health survey: normative data from the general Norwegian populationScandinavian Journal of Social Medicine, 1998